Ezrin is a cytoskeletal organizer that promotes metastasis in many cancer types by reorganizing the cytoskeleton or controlling the signal transduction [e.g., activating NF-κB, epithelial–mesenchymal transformation (EMT), and AKT pathways] (19–22). Here, AKT1 is linked to cancer.